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Abstract
Background: There is mounting evidence that our environment and lifestyle has an
impact on epigenetic regulatory mechanisms, such as DNA methylation. It has been sug-
gested that these molecular processes may mediate the effect of risk factors on disease
susceptibility, although evidence in this regard has been challenging to uncover. Using
genetic variants as surrogate variables, we have used two-sample Mendelian randomiza-
tion (2SMR) to investigate the potential implications of putative changes to DNA methyla-
tion levels on disease susceptibility.
Methods: To illustrate our approach, we identified 412 CpG sites where DNA methylation
was associated with prenatal smoking. We then applied 2SMR to investigate potential
downstream effects of these putative changes on 643 complex traits using findings from
large-scale genome-wide association studies. To strengthen evidence of mediatory
mechanisms, we used multiple-trait colocalization to assess whether DNA methylation,
nearby gene expression and complex trait variation were all influenced by the same
causal genetic variant.
Results: We identified 22 associations that survived multiple testing (P<1.89  10–7). In-
depth follow-up analyses of particular note suggested that the associations between
DNA methylation at the ASPSCR1 and REST/POL2RB gene regions, both linked with re-
duced lung function, may be mediated by changes in gene expression. We validated
associations between DNA methylation and traits using independent samples from dif-
ferent stages across the life course.
Conclusion: Our approach should prove valuable in prioritizing CpG sites that may medi-
ate the effect of causal risk factors on disease. In-depth evaluations of findings are
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necessary to robustly disentangle causality from alternative explanations such as hori-
zontal pleiotropy.
Key words: DNA methylation, Mendelian randomization, mediation, smoking, ALSPAC, ARIES
Introduction
Epigenetic factors have long been postulated as molecular
mechanisms that are responsible for mediating the effect of
causal risk factors on disease outcomes.1–4 However, evi-
dence implicating specific mechanisms across the genome
in this regard is scarce. Recent epigenome-wide association
studies (EWAS) have identified hundreds of associations
between risk factors and variation in DNA methylation
levels5–8, an epigenetic regulation process known to play a
key role in cell development and disease susceptibility.9,10
Interpreting the findings of EWAS is a challenging endeav-
our, particularly due to reverse causation and unmeasured
confounding factors that may influence results.11–13
An approach that can be used to address this challenge is
Mendelian randomization (MR), a method by which genetic
variants can be used as a proxy for modifiable exposures
to infer causality among correlated traits.14–16 Research
undertaken using the Accessible Resource for Integrated
Epigenomics Studies (ARIES) resource17 has identified
thousands of CpG sites where variation in DNA methyla-
tion levels is associated with genetic variants, known as
methylation quantitative trait loci (mQTL).18 Undertaking
MR analyses using mQTL as instrumental variables can
therefore be used to investigate potential downstream effects
of changes in DNA methylation levels on human health and
disease risk. Furthermore, under the assumptions of two-
sample MR (2SMR), it is possible to harness findings from
large-scale, well-powered genome-wide association studies
(GWAS) to obtain effect estimates for mQTL on hundreds
of complex traits across the human phenome.
We have undertaken a study that builds upon the meth-
odology established by two-step epigenetic MR19 to assess
the potential downstream effects of DNA methylation vari-
ation associated with smoking5 (Figure 1). We focus on
this exposure as a key risk factor to illustrate this approach
as previous studies have provided strong evidence that it
acts as a determinant of DNA methylation levels.20–22
Moreover, large EWAS of prenatal smoking have identi-
fied hundreds of CpG sites across the genome associated
with DNA methylation levels, which is attractive when in-
vestigating consequences of epigenetic changes as reverse
causation is extremely unlikely (i.e. prenatal smoke expo-
sure influences DNA methylation and not vice versa). We
have investigated consequences of these putative molecular
changes across the human phenome using findings from
643 large-scale GWAS. Next we applied multiple-trait
colocalization to discern whether variation in DNA meth-
ylation levels may influence traits via changes in the tran-
scription of nearby genes to associated CpG sites. Finally,
we have undertaken sensitivity analyses to explore associa-
tions in detail, as well as validation analyses using an inde-
pendent sample of young individuals to investigate
potential in utero effects.
Methods
Study population
The Avon Longitudinal Study of Parents and Children
(ALSPAC) is a population-based cohort study investigating
genetic and environmental factors that affect the health
Key Messages
• Epigenetic factors, such as DNA methylation, are biological processes that may be responsible for mediating the
effect of lifestyle exposures on disease outcomes.
• Mendelian randomization and multiple-trait colocalization can be used to assess potential consequences of adverse
risk factors for disease susceptibility due to changes in DNA methylation levels.
• In this study, we have demonstrated the value of our analytical pipeline by assessing the downstream effects of
prenatal smoking on 643 different complex traits.
• Our strongest evidence of association was observed at gene regions linked with reduced lung function, which we
evaluated using two independent populations.
• Future projects that harness increasingly large-scale molecular data should help us disentangle complex mechanisms
in epidemiology.
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and development of children. The study methods are de-
scribed in detail elsewhere23,24 (http://www.bristol.ac.uk/
alspac). Briefly, 14 541 pregnant women residents in the
former region of Avon, UK, with an expected delivery date
between 1 April 1991 and 31 December 1992, were eligi-
ble to take part in ALSPAC. Detailed information and bio-
samples have been collected on these women and their
offspring at regular intervals, and are available through a
searchable data dictionary (http://www.bris.ac.uk/alspac/
researchers/our-data/). Written informed consent was
obtained for all study participants. Ethical approval for the
study was obtained from the ALSPAC Ethics and Law
Committee and the Local Research Ethics Committees.
DNA methylation used in the study was derived using
blood samples obtained from 1018 ALSPAC mother–off-
spring pairs (mothers at two timepoints and their offspring
at three timepoints) as part of the Accessible Resource for
Integrated Epigenomic Studies (ARIES) project.17 The
Illumina HumanMethylation450 (450 K) BeadChip array
was used to measure DNA methylation at over 480 000
sites across the epigenome. Genotype data were available
for all ALSPAC individuals enrolled in the ARIES project,
which had previously undergone quality control, cleaning
and imputation at the cohort level. Details on methylation
assays, genotyping and imputation can be found in the
Supplementary Material, available as Supplementary data
at IJE online.
Identifying eligible CpG sites using results from
EWAS and the mQTL database
Prior to undertaking analysis, we identified CpG sites
across the epigenome that current findings and accessible
datasets allowed us to investigate. As an example, we
obtained a list of 2303 CpG sites that were associated with
prenatal smoking based on findings from Joubert et al.,5 us-
ing a false discovery rate (FDR)<0.01 in their analysis ad-
justed for cell counts. Next, we evaluated which of these
CpGs we were able to instrument using an mQTL. In this
study we used the mQTL database (http://www.mqtldb.
org) for this purpose, which reports SNP-methylation effect
estimates obtained from the ARIES project (http://www.ar-
iesepigenomics.org.uk/).17,18 However, there will likely be
alternative resources to this with larger sample sizes in the
forthcoming years. Moreover, future research may eventu-
ally be able to access mQTL effects derived from different
tissue types than whole blood as undertaken in this study.
As we wanted to use mQTLs as instrumental variables
for changes in DNA methylation influenced by prenatal
smoke exposure, we have only used results from the birth
timepoint in ARIES (i.e. based on DNA methylation data
derived from cord blood). Conditionally independent
mQTLs were identified in ARIES using the COJO-slct rou-
tine in GCTA25,26 and applying a threshold of P<1.0 
10–7. This threshold was merely applied as a heuristic to
identify instruments for our analysis though and future
Figure 1. An overview of the proposed two-step epigenetic Mendelian randomization approach to evaluate findings from epigenome-wide associa-
tion studies. (a) Identify CpGs sites from EWAS where a risk factor is associated with DNA methylation. Prenatal risk factors can add value as they are
very unlikely to be associated due to reverse causation. (b) Use independent cis-acting methylation quantitative trait loci (mQTL) as an instrumental
variable to proxy for changes in DNA methylation levels at this CpG site, allowing investigation into how these effects may influence complex traits.
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applications may wish to apply alternative criteria.
Furthermore, we only identified cis-mQTLs as suitable in-
strumental variables for our analysis, i.e. genetic variants
associated with proximal DNA methylation levels (<1 MB
distance away). This is because trans-mQTL are more likely
to be prone to horizontal pleiotropy, i.e. where the genetic
variant influences DNA methylation and the associated
complex trait via two independent biological pathways. As
CpG sites in ARIES are typically only independently associ-
ated with a single cis-acting mQTL, this was an important
consideration as we anticipated that downstream analyses
would be unable to robustly investigate horizontal pleiot-
ropy. However, future resources that uncover a larger num-
ber of conditionally independent mQTL to instrument CpG
sites may contemplate their inclusion in study designs.
Complex trait data from large-scale GWAS and
the UK Biobank study
We next obtained observed effects for each mQTL identi-
fied in the previous stage of our analysis on a range of com-
plex traits using large-scale studies available from the MR-
Base platform (http://www.mrbase.org).27 The following
inclusion criteria were used to select complex traits to be
analysed:
• Study samples must be larger than 1000
• Effects reported genome-wide for over 100 000 genetic
variants
• Either European or mixed populations
• Reported beta, standard error (SE) and effect alleles for
variants
We also downloaded GWAS summary statistics from the
Neale lab28 for complex traits not represented in MR-Base.
When effect estimates for complex traits were not available
for an mQTL, we identified a proxy instrument in high link-
age disequilibrium (r2> 0.8) using genotyped data from
Europe individuals as part of phase 3 (version 5) of the 1000
genomes project.29 Although we have evaluated associations
on a wide array of traits in this study, future applications
may wish to investigate hypothesis-driven relationships
depending on the environmental exposure of interest.
Statistical analysis
Two-sample Mendelian randomization
We used 2SMR to evaluate whether variation in DNA
methylation at CpG sites associated with our exposure (i.e.
prenatal smoke exposure in this study) were also associ-
ated with complex trait variation (Figure 1). When DNA
methylation levels at CpG sites only had a single cis-acting
instrument (i.e. independent cis-mQTL), MR analyses
were undertaken using the Wald ratio test.30 For single ge-
netic variant j, this can be calculated by taking the ratio of
the gene–outcome association (denoted by C^j) and the
gene–exposure association (denoted by c^j) estimates31:
b^j ¼
C^
j
c^j
Where two or more genetic instruments were available
for a CpG site, we used the inverse variance weighted
(IVW) method to obtain MR effect estimates32:
b^IVW ¼
P
jc^
2
j r
2
Yj b^j
P
jc^
2
j r
2
Yj
where rYj is the SE of the gene–outcome estimate for vari-
ant j. Although the majority of CpG sites in our study
could only be instrumented using a single genetic variant,
we expect the number of independent mQTL for a given
CpG site to increase with larger sample size mQTL studies.
As such, future applications of our approach may benefit
from using the IVW method to harness multiple indepen-
dent cis-acting variants as instrumental variables.
Furthermore, this will allow MR sensitivity analyses to be
undertaken, such as assessing heterogeneity and conduct-
ing leave-one-out analyses.
Multiple-trait colocalization
When investigating how changes in DNA methylation may in-
fluence downstream traits in an MR framework, it is impor-
tant to evaluate whether association signals may be a product
of linkage disequilibrium between two separate causal var-
iants (i.e. one influencing changes in DNA methylation and
another influencing trait variation).33,34 Furthermore, if
changes in DNA methylation at a CpG site truly influence
complex trait variation, then they are likely to be doing so via
changes in the expression of a nearby gene. We therefore ap-
plied multiple-trait colocalization35 to investigate associations
that survived multiple testing comparisons in the 2SMR
analysis (i.e. 0.05/number of CpG-trait combinations ana-
lysed). This allowed us to assess whether the genetic variant
responsible for changes in DNA methylation is also responsi-
ble for both variation in nearby gene expression and the asso-
ciated complex trait.
Multiple-trait colocalization was applied using mQTL
data from the Focus on Mother’s (FOM) timepoint in
ARIES (mean age: 47.5), GWAS summary data for the as-
sociated complex trait and expression quantitative trait
loci (eQTL) data derived from whole blood that was
obtained from the GTEx consortium v7 (n¼ 369).36
mQTL data from the FOM timepoint was used to evaluate
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whether effects observed in the previous analysis using
cord blood persisted until later life. We ran this analysis
multiple times to systematically investigate colocalization
with the expression of all genes within 100 kb of the CpG
site of interest. Analyses were only undertaken if there
were at least 50 variants (minor allele frequency 5%) in
common between all three datasets. As recommended
by the authors of this approach, a posterior probability
of association (PPA) of 80% or higher was considered
evidence of colocalization. Additionally, multiple testing
was not accounted for in these analyses as the authors of
the multiple-trait colocalization paper demonstrated that
after 500 000 simulations there was no indication of
inflated false-positive rates using this method (even with a
PPA threshold of 30%). If a CpG site was associated with
multiple correlated traits, only the trait with the highest
PPA in the colocalization analysis was taken forward.
Orienting directions of effect between traits
For associations that provided evidence of colocalization in
the previous analysis, we evaluated the direction of effect be-
tween 2SMR estimates and observed effects from the Joubert
et al. study.5 This allowed us to orient direction of effects be-
tween prenatal smoke exposure, DNA methylation and the
complex traits. Such evaluations are important to validate that
directions of effect between environmental exposures and out-
comes are consistent with evidence from the literature.
We also undertook an analysis in ALSPAC to investigate
the association between maternal smoking and any traits
with evidence of association from our MR and multiple-
trait colocalization analysis. This was to evaluate the pro-
portion of the effect mediated via changes in DNA methyla-
tion levels along the causal pathway between our exposure
and associated outcome. Analyses in this study were ad-
justed for maternal education, age and sex.
To investigate evidence of reverse causation, we evalu-
ated the association between complex traits (i.e. modelled
as our exposure) and DNA methylation (i.e. our outcome)
in a 2SMR framework. As a sensitivity analysis, we also
used the MR directionality test to assess the direction of
causality between molecular and complex traits.37 This
test was applied three times for each association, to evalu-
ate the direction between each pair of traits (i.e. DNA
methylation, gene expression and complex trait). This
allowed us to undertake an exploratory analysis regarding
the chain of direction between all three traits concerned.
Comparison of findings using two independent samples
We also repeated 2SMR analyses for the associations that
provided evidence of colocalization using two independent
samples. Along with validating findings in separate popu-
lations, this stage of our approach can be valuable in terms
of exploring the temporality of associations. For instance,
as we selected prenatal smoking as our exposure in this
study, we were interested in assessing the effect estimates
for findings at an early stage in the life course.
For this we undertook an initial analysis within the
ALSPAC cohort, using mQTL effects from ARIES participants
during childhood (mean age: 7.49 years) and effects on com-
plex traits from ALSPAC individuals not enrolled in the
ARIES project [at either the age 7, age 9 or teen focus 3 (mean
age 15.5 years) clinics]. Analyses were then repeated using
ARIES participants from the adolescence time point (mean
age: 15.5 years). This allowed us to investigate the potential
confounding effect of own smoke exposure that is more likely
to be a factor at age 15 rather than age 7. If observed associa-
tions are due to in utero effects from maternal smoke expo-
sure, then we may expect them to be observed consistently at
both timepoints. However, this analysis cannot completely
rule out own smoke exposure as a confounding factor, nor al-
ternative explanations such as offspring having shared genetics
and other environmental exposures as their parents.
The second analysis was undertaken using mQTL
effects for the same CpG sites using results from the BIOS
QTL browser38 and complex trait data from large-scale
GWAS and/or the UK Biobank study27,28 to determine MR
effect estimates in adulthood. Further publicly accessible
resources such as these in the forthcoming years should
prove beneficial for the validation stage of our approach.
Finally, to further evaluate any potential in utero effects,
we repeated our initial analysis at associated CpG sites in
the UK Biobank study.39 Here we stratified the sample
based on whether individuals answered yes or no to the
question ‘Did your mother smoke regularly around the time
when you were born?’. Stratified analyses can be insightful
in terms of better understanding putative epigenetic effects,
such as investigating the impact of prenatal exposures in our
study. However, they may require individual-level data to
undertake and as such this step of our study may not always
be possible depending upon the accessibility of data.
All analyses were undertaken using R (version 3.31).
Plots illustrating multiple trait colocalization were generated
using base R graphics. Code used in this project can be
found at https://github.com/eptgr/prenatal-CpGs. Power cal-
culations based on the effect sizes identified in this study
were undertaken using the MR power calculator.40
Results
Assessing the impact of DNA methylation
variation at birth on the human phenome
There were 412 unique CpG sites associated with prenatal
smoke exposure (FDR<0.01)5 that met our inclusion
International Journal of Epidemiology, 2019, Vol. 48, No. 3 891
D
ow
nloaded from
 https://academ
ic.oup.com
/ije/article-abstract/48/3/887/5525259 by U
niversity of Bristol Library user on 28 O
ctober 2019
criteria based on data from the ARIES project17 (Figure 1a,
Supplementary Table 1, available as Supplementary data
at IJE online). We then assessed the potential effect of
changes in DNA methylation on 643 complex traits at
these CpG sites using 2SMR (Figure 1b, Supplementary
Table 2, available as Supplementary data at IJE online).
Overall there were 22 CpG-trait associations across 12
distinct CpG sites that survived multiple testing corrections
(P<1.89  107) (Table 1 and Supplementary Table 3,
available as Supplementary data at IJE online). Among
these associations were measures of anthropometry (height
and waist-hip-ratio), lung function [forced vital capacity
and forced expiratory volume in 1 second (FEV1)], cardio-
vascular traits (low-density lipoprotein cholesterol and sys-
tolic blood pressure) and bone mineral density. A flowchart
illustrating the analysis pipeline used in this study to iden-
tify and evaluate these effects can be found in Figure 2.
Elucidating putative epigenetic mechanisms in
disease using multiple-trait colocalization
If DNA methylation levels at a CpG site truly have an im-
pact on human health and disease, then we would expect the
transcription of nearby genes to also be involved. Therefore,
to strengthen evidence of a causal association, we integrated
data on gene expression from the GTEx consortium36 for all
genes within a 100 kb distance of the CpG sites associated
with complex traits. As DNA methylation data in this study
was only available using data from whole blood, we only
used gene expression data also derived from this tissue type
from GTEx. Applying multiple-trait colocalization provided
evidence at two CpG sites that variation in gene expression,
DNA methylation and complex traits were driven by the
same underlying genetic variant (Supplementary Table 4,
available as Supplementary data at IJE online). These were
cg06105699 and cg25313468 which are located at the pro-
moter regions of the ASPSCR1 and REST genes respectively.
DNA methylation at cg06105699 colocalized with measures
of lung function and the expression of ASPSCR1 (highest
PPA¼ 1), whereas cg25313468 colocalized with measures
of lung function and the expression of POL2RB (highest
PPA¼ 0.95). Figure 3 illustrates the overlapping distribu-
tions of effects for genetic variants at the ASPSCR1 region
on FEV1, ASPSCR1 expression and DNA methylation at
cg06105699. Supplementary Figure 1, available as
Supplementary data at IJE online, provides a similar plot il-
lustrating the effect at the REST/POL2RB locus. There was
also evidence of colocalization at one other CpG site for
DNA methylation and complex traits but not gene expres-
sion (cg08685733 near C17orf53, associated with bone min-
eral density) (Supplementary Table 5, available as
Supplementary data at IJE online).
Orienting the direction of effect between prenatal
smoke exposure, molecular traits and outcomes
Using observed estimates reported by the EWAS of prenatal
smoking5 we were able to infer that prenatal smoke expo-
sure was putatively associated with reduced lung function
via methylation at the ASPSCR1 and REST/POLR2B loci.
Prenatal smoke exposure was negatively associated with
DNA methylation at ASPSCR1 [Beta: 0.008 (SE: 0.002)]
Table 1. Top findings from Mendelian randomization analysis for prenatal smoke exposure-associated CpG sites and
complex traits
CpG site Gene Complex trait MR Beta (SE) MR P PPAabc
cg26930078 C17orf53 BMD 0.093 (0.010) 1.50  1020 1.84  1005
cg02812767 LOXL1 FVC 0.051 (0.006) 3.78  1020 0.220
cg08685733 C17orf53 BMD 0.108 (0.013) 5.78  1018 0.176
cg25313468 REST Height 0.064 (0.008) 5.37  1017 9.61  1006
cg06105699 ASPSCR1 FEV1 0.053 (0.007) 7.29  1015 1
cg23184042 DLX6AS BMD 0.038 (0.005) 1.26  1014 1.31  1004
cg14150774 QSOX2 FVC 0.038 (0.005) 1.99E12 5.31  1005
cg18883198 TMEM57 LDL 0.099 (0.016) 2.72  1010 5.22  1006
cg01401641 TSHZ3 SBP 0.040 (0.007) 4.25  1009 0.158
cg01307174 ARPP-21 Worrying 0.025 (0.004) 2.65E08 0.003
cg25313468 REST FEV1 0.030 (0.006) 4.86  108 0.955
cg18089426 DLK1 Age at menarche 0.099 (0.019) 9.00  1008 1.09  1004
cg06070002 PRDX1 Waist-to-hip ratio 0.056 (0.011) 1.08  1007 9.62  1005
MR Beta (SE) units are in standard deviations (SD) meaning that 1 SD increase in DNA methylation relates to X SD change in the trait. CpG site, ID based on
Illumina mappings; Gene, as reported by Joubert et al.5 or nearest gene if not specified; MR, Mendelian randomization; SE, standard error; P, P-value; PPAabc, highest
posterior probability of association of colocalization between all 3 traits i.e. DNA methylation (a), gene expression (b) and complex trait (c) (PPAs surviving the 0.8
threshold used in this study are in bold). BMD, bone mineral density; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second; LDL, low-density lipo-
proteins; SBP, systolic blood pressure; Worrying, a Yes/No questionnaire based outcome in response to the question ‘Do you worry too long after embarrassment?’
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and our MR analysis suggests that reduced DNA methyla-
tion at this CpG site correlates with reduced lung function
[MR Beta: 0.053 (MR SE: 0.007)]. At the REST/POLR2B
locus, prenatal smoke exposure was positively associated
with DNA methylation levels [Beta: 0.012 (SE: 0.003)] and
our MR analysis suggests that increased methylation at this
CpG site also may influence reduced lung function [MR
Beta: 0.030 (MR SE: 0.006)].
We next undertook MR analyses to evaluate reverse
causation (i.e. whether genetic liability to variation in lung
function has an effect on DNA methylation at these CpG
sites), although there was no strong evidence of this (lowest
P¼ 0.026 across 20 tests) (Supplementary Table 6, avail-
able as Supplementary data at IJE online). A sensitivity
analysis using the MR directionality test complemented
these findings, as it suggested the direction of effect be-
tween molecular and complex traits at each locus was that
DNA methylation influences gene expression, which subse-
quently influences lung function (Supplementary Table 7,
available as Supplementary data at IJE online). Although
we may hypothesize that this chain of events is the most
parsimonious explanation for associations based on the
results of our study, in-depth function studies are necessary
to robustly demonstrated that this is the true underlying
causal pathway.
Our analysis with regard to maternal smoking and
FEV1 in ALSPAC identified weak evidence of association
(Beta¼0.02, SE¼ 0.01, P¼ 0.07, n¼ 5417). However,
Figure 2. Flowchart outlining the analysis pipeline used in this study along with findings from our applied example and the data resources used.
mQTL, methylation quantitative trait loci; DNAm, DNA methylation; ARIES, accessible resource for integrated epigenomics studies; GWAS, genome-
wide association studies; eQTL, expression quantitative trait loci; ALSPAC, Avon Longitudinal Study of Parents and Children.
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the direction of effect in this analysis was consistent with
oriented effects between prenatal smoke exposure, CpGs
and FEV1 (i.e. maternal smoking is associated with re-
duced lung function). We were however unable to investi-
gate the proportion of effect potentially mediated between
our exposure and outcome via changes in DNA methyla-
tion in this analysis. Future studies interested in applying
our approach in larger samples sizes may benefit from in-
vestigating the proportion potentially mediated along puta-
tive causal pathways using well-powered effect estimates.
Validation of results using multiple timepoints
over the life course
We investigated the observed associations at the two CpG
sites of interest during early stages in the life course using
data from the ALSPAC cohort.23 There was weak evidence
that DNA methylation levels at either CpG site was associ-
ated with FEV1 at age 8 (ASPSCR1—MR Beta
(SE)¼0.017 (0.010), P¼ 0.086, noutcome¼ 5552; REST/
POL2RB—MR Beta (SE) ¼ 0.014 (0.012), P¼ 0.226,
noutcome¼ 4644). However, evidence was stronger at age
15.5 despite having a smaller sample size (ASPSCR1—MR
Beta (SE)¼0.073 (0.029), P¼ 0.013, noutcome¼3852;
REST/POL2RB—MR Beta (SE)¼ 0.078 (0.032),
P¼ 0.016, noutcome¼ 3240). Full results from this analysis
can be found in Supplementary Table 8, available as
Supplementary data at IJE online. As smoking initiation is
likely to be more prevalent at age 15 rather than age 8,
these findings support a role for own smoking (or environ-
mental smoke exposure) influencing lung function via
changes in DNA methylation levels, as opposed to an in
utero effect due to maternal smoke exposure. Our split
sample MR analysis using data from the UK Biobank sup-
ported this, as the observed associations were not confined
to the subset of individuals who reported exposure to ma-
ternal smoking around birth (Supplementary Table 9,
available as Supplementary data at IJE online).
We also evaluated these effects using data obtained dur-
ing adulthood that provided strong evidence of association
between DNA methylation at these loci and their relevant
traits (ASPSCR1—MR Beta (SE)¼0.025 (0.005),
P¼ 9.23  10–08, noutcome¼ 307 638; REST/POL2RB—
MR Beta (SE)¼ 0.034 (0.005), P¼ 2.90  1013,
noutcome¼ 307 638). This was undertaken in an indepen-
dent sample of individuals to the analysis in adolescence,
as we used mQTL data from the BIOS QTL browser38 and
the UK Biobank study.39 These findings therefore help vali-
date the robustness of these associations, as well as sug-
gesting that own smoke exposure may be more likely to be
responsible for putative effects rather than maternal smoke
exposure. Moreover, the direction of MR effects at both
loci were consistent between the population of adults and
adolescents (Supplementary Table 8, available as
Supplementary data at IJE online).
Discussion
In this study we have proposed a pipeline of analytical
techniques to investigate the potential functional implica-
tions of associations between lifestyle risk factors and
Figure 3. Illustration of genetic colocalization at the ASPSCR1 locus between gene expression and lung function (left) as well as DNA methylation at
CpG site cg06105699 and lung function (right). Overlapping distributions of –log10 P-values for the effects of genetic variants at the ASPSCR1 gene re-
gion on forced expiratory volume in 1 second (FEV1) (grey), gene expression of ASPSCR1 in whole blood (blue) and DNA methylation at cg06105699
(red). Genes at this region are annotated below the x-axis, where a red cross indicates the position of the associated CpG site. Multiple-trait colocaliza-
tion provides strong evidence that FEV1, ASPSCR1 expression and DNA methylation at cg06105699 all share the same underlying causal variant at
this locus. This supports evidence that changes in DNAmethylation at this CpG site may influence lung function via changes in gene expression.
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measures of DNA methylation. We have illustrated this
approach by evaluating CpG sites previously linked with
maternal smoke exposure, where the strongest evidence of
association suggested that putative smoke exposure-
associated epigenetic changes may potentially influence re-
duced lung function at the ASPSCR1 and REST/POL2RB
loci via changes in gene expression. The other association
signals detected by this study require further validation to
robustly link DNA methylation variation with later life
outcomes, although upcoming datasets across various tis-
sue types will facilitate such endeavours. Furthermore, this
proposed pipeline should prove valuable for future studies
that harness these forthcoming datasets and findings of
large-scale EWAS. Doing so will help uncover putative epi-
genetic mechanisms that may play a mediatory role be-
tween risk factors and disease.
DNA methylation variation at either the ASPSCR1 or
REST/POL2RB locus has not previously been associated
with measures of lung function by published EWAS.41,42 A
possible explanation for this could be the reasonably mod-
est sample sizes analysed in these studies (n¼ 100 and
n¼ 172, respectively), which may be attributed to the cur-
rent costs of DNA methylation sequencing assays. This
highlights the strength of our pipeline in terms of leverag-
ing summary statistics from a large-scale consortium in a
2SMR framework, thus circumventing the requirement of
having DNA methylation and trait measurements in the
same population. Furthermore, this allows our pipeline to
evaluate associations with a wide array of traits, which
again would be challenging in a one-sample setting. We
note however that as larger sample sizes become available
for EWAS it would be valuable to compare observational
effect estimates with findings from MR analyses. This is
particularly important given that observational estimates
may be biased and disguise a true underlying relationship.
There was an inverse relationship between prenatal
smoke exposure and lung function potentially mediated by
epigenetic variation at ASPSCR1 and REST/POL2RB,
which is in line with evidence from the literature concern-
ing exposure to tobacco smoke early in the life course and
later-life lung function.43,44 We also observed consistent
directions of effect and associations between DNA methyl-
ation and lung function at these loci in two separate popu-
lations. Interestingly, the association observed using
individuals from the ALSPAC cohort was stronger when
using measures of lung function from the age 15 timepoint
compared with the age 8 one, despite having a smaller
sample size (n¼ 3852 and 3240 vs n¼ 5552 and 4644 re-
spectively). This implies that these associations are unlikely
to be attributed to an in utero effect due to maternal smoke
exposure. Furthermore, it may be that the most parsimoni-
ous explanation for these results is that both genetics and
risk factors such as prenatal smoke exposure collectively
influence traits via changes in DNA methylation. That be-
ing said, this approach should still prove useful for future
studies interested in identifying in utero effects, although
as demonstrated by this study we advise using a cohort of
young individuals to evaluate findings. Identifying specific
epigenetics mechanisms that can explain in utero effects is
a challenging but potentially extremely rewarding area of
research.45
The association signal we detected in this study at
cg25313468 corresponds to a CpG site that resides near
the promoter region of the REST gene. However, the
strongest evidence of co-localization was detected with the
expression of the neighbouring POL2RB gene, along with
DNA methylation at this CpG site and FEV1. The func-
tional gene responsible for this putative association is
therefore unclear, as is whether there may be in fact multi-
ple genes at this locus whose transcription may be influ-
enced by potential changes in DNA methylation due to
prenatal smoke exposure. The REST gene encodes the
RE1-silencing transcription factor that has been reported
to be a transcriptional repressor.46,47 Although this has
been principally linked to neuronal genes in non-neuronal
tissues,47 there is also previous evidence suggesting that
REST functions as a master regulator of gene repression in
response to hypoxia (deprivation of adequate oxygen
reaching tissues).48 There is also previous evidence that
maternal RE1-silencing transcription factor regulates the
expression of 158 genes, which may have implications in
both development and long-term phenotypes.49 In con-
trast, evidence implicating the POL2RB gene at this locus
is less clear, although epigenetic regulation of POL2RA
has been previously linked with childhood wheezing due to
maternal stress.50
At the other CpG site with evidence of association in
this study, concerning DNA methylation at cg06105699,
there was evidence of colocalization with two nearby genes
(ASPSCR1 and LRR45). ASPSCR1 is a candidate gene for
alveolar soft part sarcoma (ASPS), a rare type of soft tissue
sarcoma that typically occurs in young patients and often
spreads to the lungs, brain and bone.51 There is evidence to
suggest that this is due to oncogenic rearrangement with
the transcription factor gene TFE3.52 The function of
LRRC45 is less clear, although it is known to play a role in
centrosome cohesion.53 Further analyses are therefore re-
quired to separate co-expression between these proximal
genes to better understand the potential effect at this locus.
Our proposed split sample analysis using UK Biobank
data should prove useful for future studies wishing to eval-
uate putative associations for certain exposures, such as
prenatal smoking that was investigated in this study.
Furthermore, exploring associations between an exposure
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and outcome across multiple timepoints can enhance un-
derstanding of temporal effects. In this study we undertook
these types of analyses to demonstrate that associations are
more likely to be attributed to own smoking (or possibly
environmental smoke exposure) rather than an in utero ef-
fect. However, we appreciate that the feasibility of under-
taking these analyses in future studies may depend on the
accessibility of appropriate datasets in large sample sizes.
As such, design choices should be carefully considered be-
fore applying our pipeline to investigate a research ques-
tion. Longitudinal cohorts such as ALSPAC can be
extremely useful in terms of exploring the temporality of
effects, whereas richly phenotyped resources such as UK
Biobank are powerful for independent validation. We also
undertook some power calculations based on the effect
sizes observed in our own study regarding lung function
traits (which typically ranged from 0.03 to 0.05 standard
deviation increase in outcome per standard deviation
change in exposure). These results suggest that harnessing
summary statistics from biobank-scale datasets consider-
ably helps in achieving adequate statistical power for the
types of analyses proposed in our study (Supplementary
Figure 2, available as Supplementary data at IJE online).
A limitation of this study is the lack of tissue-specific
data at birth, which is why we have used DNA methylation
data derived from whole blood. Incorporating DNA methyl-
ation and gene expression data from different tissue types
should therefore improve this analysis pipeline’s potential to
help elucidate epigenetic mechanisms in disease, as both are
known to be tissue-specific. This is the phenomenon
whereby a gene’s function may be restricted to certain tissue
types that may be relevant for a given disease.54 This is im-
portant as DNA methylation data derived from cord blood
may only be acting as a proxy for a more relevant tissue
type. For example, in this study this could be lung tissue
given the associations we detected with measures of lung
function. In-depth tissue-specific evaluations of the associa-
tion signals detected in whole blood would therefore be
worthwhile once such datasets concerning DNA methyla-
tion become available.55 Added complexities (such as multi-
ple testing) when analysing various tissue types will need to
be carefully considered in these study designs. However, as
sample sizes for publicly available molecular datasets in-
crease, so too will the necessary power required to detect
associations similar to the two CpG sites highlighted in our
study. This should facilitate mechanistic insight into the
causal pathway between risk factors and later life outcomes,
as well as disentangling co-expression between neighbouring
genes, which is another current limitation in the field when
evaluating signals. However, in the meantime there is in-
creasing evidence that mQTL derived from blood act as a
surprisingly adequate proxy for other tissue types.56
The approach demonstrated by this study should prove
valuable in prioritizing genes to investigate the biological
mechanisms that may explain associations between modifi-
able risk factors and disease susceptibility. The rewards for
this challenging endeavour are promising, as it will allow
us to use epigenetic factors as an indicator for early disease
prognosis and subsequently improve health care and
treatment.
Supplementary data
Supplementary data are available at IJE online.
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